期刊文献+

甲状腺乳头状癌预后多因素分析 被引量:34

Multivariate Regression Analysis of Papillary Thyroid Carcinoma Prognosis
下载PDF
导出
摘要 目的:探讨影响甲状腺乳头状癌预后的相关临床等因素。方法:选择该院1954年6月至1996年12月收治的1574例甲状腺乳头状癌患者,分析临床病理因素与预后的关系。根据COX回归模型的结果计算预后指数(prognostic index,PI),PI=β1x1+β2x2+···+βnxn(β1~-βn均为各变量回归系数,x1-xn为各变量等级值)。并根据PI值将患者分为不同的危险组,比较各组的生存率。结果:本组中位随访时间为16年。全组总的5、10、15、20年生存率分别为96.2%、92.1%、89.0%、86.2%。单因素分析显示,性别、有无淋巴结及远处转移、肿瘤大小、年龄、包膜侵犯情况、手术切除情况、临床分期与预后有关。多因素分析显示,性别、年龄、肿瘤大小、肿瘤侵犯程度、分期、淋巴结转移、远处转移是影响预后的重要因素。PI=0.056×(年龄)+0.402×(肿瘤侵犯程度)+0.062×(肿瘤大小)+0.224×(分期)+1.207×(远处转移)-0.589×(性别)。根据PI值将患者分为低危组(PI≤2.765),中危组(2.765<PI<5.152),高危组(PI≥5.152),低危组5、10、15、20年生存率为99.6%、98.3%、97.7%、95.1%;中危组5、10、15、20年生存率为95.5%、87.8%、84.7%、81.1%;高危组5、10、15、20年生存率为64.0%、49.5%、29.4%、19.3%。两两之间比较存在统计学差异(P=0.000)。结论:性别、年龄、肿瘤大小、肿瘤侵犯程度、分期、远处转移是影响甲状腺乳头状癌预后的重要因素。PI值可作为甲状腺乳头状癌患者预后的估计。 Objective: To investigate the clinical factors related to the prognosis of papillary thyroid carcinoma. Methods: The clinical materials and follow-up data of 1.574 cases with papillary thy- roid carcinoma seen in Tianjin Cancer Institute & Hospital from June 1954 to December 1996 were analyzed retrospectively. The prognostic index (PI) of patients was calculated on the basis of the results of multivariate analysis. According to PI values, patients were classified into different hazard groups. Resuits: The 5-, 10-, 15-, and 20-year survival rates were 96%, 92%, 89%, and 86%, respectively. U- nivariate analysis showed thai gender, age, lymph node metastases, distant metastases, tumor size, ex- tent of tumor invasion, surgery modality, and clinical stage were associated with prognosis. Multivariate analysis showed that gender, age, tumor size, extent of tumor invasion, clinical stage, and distant metastases were prognostic factors. The patients were classified into low-risk, moderate-risk and highrisk groups according to the PI value. The 5-, 10-, 15-, and 20-year survival rate was 99.6%, 98.3%, 97.7%, and 95.1% in the low-risk group; 95.5%, 87.8%, 84.7%, and 81,1% in the moderate-risk group; and 64.0%, 49.5%, 29.4%, and 19.3% in the high-risk group. There was a significant difference among the groups (P〈0.05). Conclusion: Gender, age, tumor size, extent of tumor invasion, clinical stage, and distant metastases are important prognostic factors in papillary thyroid carcinoma. Moreover, PI value can be used to develop a prognosis for patients with PTC.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2007年第22期1294-1297,共4页 Chinese Journal of Clinical Oncology
关键词 甲状腺乳头状癌 预后 生存率 预后指数 Papillary thyroid carcinoma Prognosis Survival rate Prognostic index
  • 相关文献

参考文献10

  • 1孙彦,王琪.2002年AJCC甲状腺癌分期方案[J].国外医学(耳鼻咽喉科学分册),2004,28(6):385-386. 被引量:11
  • 2钱碧云,陈可欣,何敏,董淑芬,韩宏伟,雷蕾,王继芳.天津市区甲状腺癌流行状况调查[J].中国肿瘤临床,2005,32(4):218-221. 被引量:56
  • 3Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a majordeterminant of survival in low-or high-risk papillary thyroid cancer[J]. Ann Surg Oncol, 2005, 12(1): 81-89.
  • 4Lang BH, Lo CY, Chan WF, et al. Staging systems for papillary thyroid carcinoma: a review and comparison [J]. Ann Surg, 2007, 245(3): 366-378.
  • 5Weber T,Schilling T, Buchler MW. Thyroid carcinoma [J]. Curr Opin Oncol, 2006, 18(1): 30-35.
  • 6Cushing SL, Palme CE, Audet N, et al. Prognostic factors in well-differentiated thyroid carcinoma[J]. Laryngoscope, 2004, 114 (12): 2110-2115.
  • 7Falvo L, Catania A, D Andrea V, et al. Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma[J]. Ann Surg, 2005, 241(4): 640-646.
  • 8Kim JM, Kim TY, Kim WB, et al. Lymphovascular invasion is associated with lateral cervical lymph node metastasis in papillary thyroid carcinoma[J]. Laryngoscope, 2006, 116(11): 2081-2085.
  • 9韩德民,于振坤,主译.头颈外科学与肿瘤学[M].第三版.北京:人民卫生出版社,2003.435-.436
  • 10张仑,李树玲.1 173例甲状腺乳头状癌外科治疗远期疗效观察[J].中国肿瘤临床,2003,30(11):805-808. 被引量:59

二级参考文献18

  • 1Larijani B, Shirzad M, Mohagheghi MA, et al. Epidemiologic analysis of the Tehran Cancer Institute Data System Registry(TCIDSR)[J]. Asian Pac J Cancer Prev, 2004, 5(1):36-39.
  • 2Loh KG, Greenspan FS, Gee L, et al. Pathological tumor-nodemetastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients[J].J Glin Endocrinol Metab, 1997, 82(11):3553-3562.
  • 3Zhumadiiov Z, Gusev BI, Takada J, et al. Thyroid abnormality trend over time in northeastern regions of Kazakstan, adjacent to the Semipalatinsk nuclear test site: a case review of pathological findings for 7271 patients[J].J Radiat Res, 2000, 41 (1):35-44.
  • 4Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2000. Cancer Incidence, Mortality and Prevalence Worldwide [M]. IARC press Lyon, 2001.
  • 5Zheng T, Holford TR, Chen Y, et al. Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut,1935-1992[J]. Int J Cancer, 1996, 67 (4):504-509.
  • 6Remontet L, EsteveJ, Bouvier AM. Cancer incidence and mortality in France over the period 1978-2000 [J]. Rev Epidemiol Sante Publique, 2003, 51 (1):3-30.
  • 7Akslen LA, Haldorsen T, Thoresen SO, et al. Incidence of thyroid cancer in Norway 1970-1985. Population review on time trend, sex, age, histological type and tumour stage in 2625 cases [J]. APMIS, 1990, 98(6):549-558.
  • 8Tai P, Mould R, Prysyaztmyuk A, et al. Descriptive epidemiology of thyroid carcinoma[J]. Curr Oncol, 2003, 10(1):54-65.
  • 9Ivanov VK, Tsyb AF, Nilova EV, et al. Cancer risks in the Kaluga oblast of the Russian Federation 10 years after the Chernobyl accident[J].Radiat Environ Biophys, 1997, 36(3):161-167.
  • 10Adami HO, Hunter D, Trichopoulos D. Textbook of Cancer Epidemiology [M]. New York Oxford University Press. 2002.504-519.

共引文献122

同被引文献345

引证文献34

二级引证文献227

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部